Akero Therapeutics, Inc.

NASDAQ:AKRO

28.25 (USD) • At close December 27, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017
Operating Activities:
Net Income -151.759-112.033-100.777-79.207-43.755-81.714-4.564
Depreciation & Amortization 0.0290.0430.0410.017-0.10400
Deferred Income Tax 001.0710.0830.10400
Stock Based Compensation 21.49723.24310.0546.0221.770.1210
Change In Working Capital -6.67-4.4599.7272.0856.4621.0610.182
Accounts Receivables 0000000
Inventory 0000000
Accounts Payables -0.6450.9683.2732.481-0.4261.3130.06
Other Working Capital -6.025-5.4276.454-0.3966.888-0.2520.122
Other Non Cash Items -8.4640.6890.2030.196-0.10475.907-0.06
Operating Cash Flow -145.367-92.517-79.681-70.804-35.627-4.625-4.382
Investing Activities:
Investments In Property Plant And Equipment 000-0.1480-50
Acquisitions Net 0000.01000
Purchases Of Investments -433.123-101.446-43.561-115.037-71.51300
Sales Maturities Of Investments 209.537.62185.841105.424000
Other Investing Activites 0-0.0640.042-0.01-0.072-0.0050
Investing Cash Flow -223.623-63.82542.28-9.761-71.513-50
Financing Activities:
Debt Repayment 151000000
Common Stock Issued 335.429241.20.602202.55495.45285.0075
Common Stock Repurchased 000.3730000
Dividends Paid 0000000
Other Financing Activities 2.8874.4320.6020.5530.53685.0075
Financing Cash Flow 353.316255.6320.602203.10795.98885.0075
Other Information:
Effect Of Forex Changes On Cash 0000000
Net Change In Cash -15.67499.29-36.799122.542-11.15275.3820.618
Cash At End Of Period 234.207249.881150.591187.3964.848760.598